News

Zacks Investment Research on MSN1h
MCK Stock Up 24% YTD: Should You Buy, Hold or Sell Before Q4 Earnings?
McKesson Corporation MCK is scheduled to report fourth-quarter fiscal 2025 results on May 8, after market close. The company ...
Zacks Investment Research on MSN1h
Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to earnings of $0.34 per share a year ago. These ...
Corbus Pharmaceuticals: Q1 Earnings Snapshot
NORWOOD, Mass. (AP) — NORWOOD, Mass. (AP) — Corbus Pharmaceuticals Holdings Inc. (CRBP) on Tuesday reported a loss of $17 million in its first quarter. On a per-share basis, the Norwood, Massachusetts ...
The Zacks Analyst Blog Highlights Baidu, Tencent and Alibaba
China’s tech giants Baidu and Tencent Holdings Ltd. have both emerged as major players in the artificial intelligence (AI) ...
Zacks.com on MSN2h
Should You Invest in the SPDR S&P Semiconductor ETF (XSD)?
You should consider the SPDR S&P Semiconductor ETF (XSD), a passively managed exchange traded fund launched on 01/31/2006. An increasingly popular option among retail and institutional investors, ...